SEC Form 4 · accession 0001562180-17-003374
BIO-TECHNE Corp · TECH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Harold J Wiens
Director
Period of report
Oct 26, 2017
Accepted (ET)
Oct 30, 2017 · 4:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000842023
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 26, 2017 | A | 739 | $0.00 | A | 4,212 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $125.05 | Oct 26, 2017 | A | 3,125 | A | — | Oct 26, 2027 | Common Stock | 3,125 | 3,125 | D |
| Stock Option (right to buy) | $91.78 | holding | — | — | — | Oct 30, 2014 | Oct 30, 2024 | Common Stock | 4,000 | 4,000 | D |
| Stock Option (right to buy) | $87.83 | holding | — | — | — | May 15, 2014 | May 15, 2024 | Common Stock | 2,000 | 2,000 | D |
| Stock Option (right to buy) | $87.34 | holding | — | — | — | Oct 29, 2016 | Oct 28, 2025 | Common Stock | 4,260 | 4,260 | D |
| Stock Options (Right to buy) | $101.19 | holding | — | — | — | Oct 26, 2017 | Oct 26, 2026 | Common Stock | 3,985 | 3,985 | D |
Explanation of responses
- F1The option vests on the earlier of the one year anniversary of the grant date (10/26/18) or the date of Bio-Techne's 2018 annual meeting of shareholders.